agenovir corporation logo

Agenovir Corporation

Agenovir Corporation engages in the research and development of anti-viral therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. It uses nucleases, including CRISPR/Cas9 to target viral DNA for disruption.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.agenovir.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
499 Illinois Street, Suite 500 San Francisco, CA 094158
California
United States
Email
Contact Number
650-491-9624

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/agenovir-corporation” connections=”true” suffix=””]